Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01ZUN
|
||||
Former ID |
DNC009202
|
||||
Drug Name |
3,3-di(pent-4-enyl)azetidin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529529] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H21NO
|
||||
Canonical SMILES |
C=CCCCC1(CNC1=O)CCCC=C
|
||||
InChI |
1S/C13H21NO/c1-3-5-7-9-13(10-8-6-4-2)11-14-12(13)15/h3-4H,1-2,5-11H2,(H,14,15)
|
||||
InChIKey |
RZYCKKZEBQDDLK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529529] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.